Effect of Using Triclosan-Impregnated Polyglactin Suture to Prevent Infection of Saphenectomy Wounds in CABG: A Prospective, Double-Blind, Randomized Clinical Trial.


Journal

Brazilian journal of cardiovascular surgery
ISSN: 1678-9741
Titre abrégé: Braz J Cardiovasc Surg
Pays: Brazil
ID NLM: 101677045

Informations de publication

Date de publication:
01 12 2019
Historique:
entrez: 14 11 2019
pubmed: 14 11 2019
medline: 4 12 2019
Statut: epublish

Résumé

To evaluate the efficacy of triclosan-coated suture for the reduction of infection in saphenectomy wounds of patients undergoing coronary artery bypass graft (CABG) surgery. A total of 508 patients who underwent saphenectomy in CABG surgery were included in a prospective, randomized, double-blind trial from February/2011 to June/2014. Patients were randomized into the triclosan-coated suture group (n= 251) and the conventional non-antibiotic suture group (n=257). Demographic (gender and age), clinical (body mass index, diabetes, and use of analgesics), and intraoperative (cardiopulmonary bypass and cross-clamp times) variables and those related to the saphenectomy wound (pain, dehiscence, erythema, infection, necrosis, and hyperthermia) were measured and analyzed. Of the 508 patients who underwent saphenectomy, 69.9% were males and 40.2% were diabetic. Thirty-three (6.5%) patients presented infection: 13 (5.3%) with triclosan and 20 (7.9%) with conventional suture (P=0.281). Among diabetic patients (n=204), triclosan suture was used in 45.1% with four cases of infection; conventional suture was used in 54.9% of them, with 11 cases of infection. Most patients (94.3%) underwent on-pump CABG. Wound pain was observed in 9.9% of patients with triclosan-coated suture and in 17.9% with conventional suture (P=0.011). Wound hyperthermia was found in 1.6% of patients with triclosan-coated suture and in 5.4% of those with conventional suture (P=0.028). Triclosan-coated suture shows lower infection rate in saphenectomy of patients undergoing CABG, although the differences were not statistically significant. Pain and wound hyperthermia were less frequent in patients with triclosan-coated sutures compared with conventional sutures.

Identifiants

pubmed: 31719010
doi: 10.21470/1678-9741-2019-0048
pmc: PMC6852449
doi:

Substances chimiques

Anti-Infective Agents, Local 0
Polyglactin 910 34346-01-5
Triclosan 4NM5039Y5X

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

588-595

Références

Ann Thorac Surg. 2003 Dec;76(6):2141-6
pubmed: 14667670
Nature. 1998 Aug 6;394(6693):531-2
pubmed: 9707111
Interact Cardiovasc Thorac Surg. 2012 Sep;15(3):411-5
pubmed: 22691378
Arq Bras Cardiol. 2009 Nov;93(5):555-60
pubmed: 20084319
Lasers Med Sci. 2018 Jan;33(1):103-109
pubmed: 29027034
J Am Coll Cardiol. 2013 Jan 29;61(4):e78-e140
pubmed: 23256914
J Thorac Cardiovasc Surg. 1981 Mar;81(3):403-7
pubmed: 7464203
Eur J Cardiovasc Nurs. 2017 Feb;16(2):136-142
pubmed: 27036953
Rev Bras Cir Cardiovasc. 2008 Jul-Sep;23(3):III-VII
pubmed: 19082314
Anesth Analg. 1997 Oct;85(4):766-82
pubmed: 9322454
J Thorac Cardiovasc Surg. 2003 Oct;126(4):992-9
pubmed: 14566237
Br J Surg. 2017 Jan;104(2):e118-e133
pubmed: 28093723
J Hosp Infect. 2004 May;57(1):14-24
pubmed: 15142711
Ann Med Surg (Lond). 2016 Feb 17;7:1-6
pubmed: 27006766
Eur Heart J. 2014 Oct 1;35(37):2541-619
pubmed: 25173339
J Surg Educ. 2011 Mar-Apr;68(2):101-4
pubmed: 21338964
Ann Thorac Surg. 1998 Nov;66(5):1626-31
pubmed: 9875762
Crit Care Nurs Clin North Am. 2017 Mar;29(1):1-13
pubmed: 28160951
Circulation. 2005 Aug 30;112(9 Suppl):I358-65
pubmed: 16159846
Medicine (Baltimore). 2017 Jan;96(3):e5925
pubmed: 28099357
Rev Bras Cir Cardiovasc. 2014 Oct-Dec;29(4):513-20
pubmed: 25714203
Rev Bras Cir Cardiovasc. 2009 Jan-Mar;24(1):68-72
pubmed: 19504022
Eur J Clin Microbiol Infect Dis. 2017 Jan;36(1):19-32
pubmed: 27590620
Eur J Cardiothorac Surg. 2013 Nov;44(5):931-8
pubmed: 23435526
Surg Infect (Larchmt). 2005 Fall;6(3):313-21
pubmed: 16201941

Auteurs

Paulo Samuel Santos (PS)

Instituto Nacional de Cardiologia Department of Cardiovascular Surgery Rio de Janeiro RJ Brazil Department of Cardiovascular Surgery, Instituto Nacional de Cardiologia (INC), Rio de Janeiro, RJ, Brazil.

Marisa Santos (M)

Instituto Nacional de Cardiologia Núcleo de Avaliação de Tecnologia em Saúde Rio de Janeiro RJ Brazil Núcleo de Avaliação de Tecnologia em Saúde (NATS), Instituto Nacional de Cardiologia (INC), Rio de Janeiro, RJ, Brazil.

Alexandre Siciliano Colafranceschi (AS)

Instituto Nacional de Cardiologia Department of Cardiovascular Surgery Rio de Janeiro RJ Brazil Department of Cardiovascular Surgery, Instituto Nacional de Cardiologia (INC), Rio de Janeiro, RJ, Brazil.

Andrea Nunes de Souza Pragana (ANS)

Instituto Nacional de Cardiologia Department of Cardiovascular Surgery Rio de Janeiro RJ Brazil Department of Cardiovascular Surgery, Instituto Nacional de Cardiologia (INC), Rio de Janeiro, RJ, Brazil.

Marcelo Goulart Correia (MG)

Instituto Nacional de Cardiologia Department of Biostatistics and Bioinformatics Rio de Janeiro RJ Brazil Department of Biostatistics and Bioinformatics, Instituto Nacional de Cardiologia (INC), Rio de Janeiro, RJ, Brazil.

Heloisa Helena Simões (HH)

Instituto Nacional de Cardiologia Department of Cardiovascular Surgery Rio de Janeiro RJ Brazil Department of Cardiovascular Surgery, Instituto Nacional de Cardiologia (INC), Rio de Janeiro, RJ, Brazil.

Fernando Alves Rocha (FA)

Instituto Nacional de Cardiologia Department of Cardiovascular Surgery Rio de Janeiro RJ Brazil Department of Cardiovascular Surgery, Instituto Nacional de Cardiologia (INC), Rio de Janeiro, RJ, Brazil.

Maria Eduarda de Vasconcelos Soggia (MEV)

Instituto Nacional de Cardiologia Department of Cardiovascular Surgery Rio de Janeiro RJ Brazil Department of Cardiovascular Surgery, Instituto Nacional de Cardiologia (INC), Rio de Janeiro, RJ, Brazil.

Ana Paula Malta Samuel Santos (APMS)

Instituto Nacional de Cardiologia Department of Cardiovascular Surgery Rio de Janeiro RJ Brazil Department of Cardiovascular Surgery, Instituto Nacional de Cardiologia (INC), Rio de Janeiro, RJ, Brazil.

Annie de Azeredo Coutinho (AA)

Instituto Nacional de Cardiologia Núcleo de Avaliação de Tecnologia em Saúde Rio de Janeiro RJ Brazil Núcleo de Avaliação de Tecnologia em Saúde (NATS), Instituto Nacional de Cardiologia (INC), Rio de Janeiro, RJ, Brazil.

Matheus Swarovsky Figueira (MS)

Instituto Nacional de Cardiologia Department of Cardiovascular Surgery Rio de Janeiro RJ Brazil Department of Cardiovascular Surgery, Instituto Nacional de Cardiologia (INC), Rio de Janeiro, RJ, Brazil.

Bernardo Rangel Tura (BR)

Instituto Nacional de Cardiologia Department of Biostatistics and Bioinformatics Rio de Janeiro RJ Brazil Department of Biostatistics and Bioinformatics, Instituto Nacional de Cardiologia (INC), Rio de Janeiro, RJ, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH